AseBio
Registrarse
Registrarse
Registrarse

ProductoActualizado el 17 de julio de 2026

Alzheimer Research Antibody Portfolio

CEO en BIOCLONAL

ZARAGOZA, España

Acerca de

BioClonal is developing a focused portfolio of research antibodies against key targets involved in Alzheimer's disease pathology. Our catalog includes antibodies against Amyloid-beta species, toxic oligomers, Tau-related epitopes and emerging biomarkers associated with neurodegeneration.

Designed for research applications, these antibodies aim to support biomarker discovery, assay development and the understanding of disease mechanisms, providing highly specific tools for academic institutions, biotech companies and diagnostic developers working in Alzheimer's disease.

Organización

BIOCLONAL

ZARAGOZA, España

Oportunidades similares